0000925421-17-000358.txt : 20170925
0000925421-17-000358.hdr.sgml : 20170925
20170925172204
ACCESSION NUMBER: 0000925421-17-000358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170922
FILED AS OF DATE: 20170925
DATE AS OF CHANGE: 20170925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krishnan Krish S
CENTRAL INDEX KEY: 0001298709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 171100485
MAIL ADDRESS:
STREET 1: 1881 GROVE AVENUE
CITY: RADFORD
STATE: VA
ZIP: 24141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810930882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-09-22
0001711279
Krystal Biotech, Inc.
KRYS
0001298709
Krishnan Krish S
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
1
1
1
0
President and CEO
Common Stock
2017-09-22
4
P
0
100000
10.00
A
1935249
D
Common Stock
2017-09-22
4
C
0
112162
A
112162
I
By trust
Common Stock
1935249
I
By spouse
Series A Convertible Preferred Stock
2017-09-22
4
C
0
112162
0
D
Common Stock
112162
0
I
By trust
The Series A convertible preferred stock converted on a one-to-one basis into 112,162 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.
Directly beneficially owned by the Krishnan Family Trust. The reporting person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.
Directly beneficially owned by Suma M. Krishnan, the spouse of the reporting person.
/s/ Katherine A. Shaia, as attorney-in-fact for Krish S. Krishnan
2017-09-25